Market & TrendsMay 13, 2026·4 min read read·Last updated: May 13, 2026

VC Funding Digest: May 13, 2026 — Notable Startup Rounds

Defense AI and agentic software are pulling institutional capital away from pure foundation model bets. Round sizes remain elevated but sector mix is shifting — investors are betting on applied AI with near-term government and enterprise contracts rather than another frontier lab.

TC
Trace Cohen
3x founder, 65+ investments, building Value Add VC

Quick Answer

VC deal flow in mid-May 2026 is rotating toward applied AI — defense tech, agentic workflow automation, and healthcare AI — as foundation model bets mature. The tracked rounds this week total over $6B across eight companies. Defense AI alone accounts for roughly 30% of total capital, reflecting sustained DoD contract momentum and increased LP comfort with dual-use technology investment.

The sector rotation has begun. Defense AI and agentic workflow are replacing raw foundation model bets.

Mid-May 2026 deal flow tells a clear story: institutional capital is moving up the stack. Investors who spent 2024–2025 backing compute infrastructure and frontier labs are now writing checks into companies with real government contracts, enterprise deployments, and clinical validations. Here are the notable rounds from this week.

Notable Rounds: May 13, 2026

CompanyAmountStageSectorLead Investor
Anduril Industries$1.5BSeries FDefense AIAndreessen Horowitz / Founders Fund
Harvey AI$500MSeries DLegal AISequoia Capital
Glean$350MSeries EEnterprise AI SearchGeneral Catalyst
Abridge$275MSeries CHealthcare AILightspeed Venture Partners
Cognition (Devin)$250MSeries BAgentic AI / Dev ToolsFounders Fund
Perplexity AI$500MSeries DAI SearchSoftBank Vision Fund
Cohere$450MSeries D+Enterprise LLMsPSP Investments / Nvidia
Navan (extension)$200MSeries GAI-Powered T&EGoldman Sachs Growth

Deal Flow Patterns

Anduril's $1.5B round is the largest defense-native venture round since Palantir's late-stage raises — the signal is that DoD contract velocity is outpacing earlier projections

Harvey AI and Cognition together represent a $750M bet on autonomous professional workflows — legal, code, and knowledge work are converging into a single agentic stack

Abridge's $275M raise reflects hospital system demand for AI-assisted clinical documentation — ambient AI notes are being piloted in 300+ health systems nationwide

Cohere's round is notable for the Nvidia strategic co-investment — chipmakers are now routinely co-investing to lock in preferred infrastructure customers at scale

What to Watch

Anduril's TITAN contract expansion

The Army's TITAN ground station program is Anduril's largest government contract to date. Watch for follow-on awards in Q3 2026 — they will set the revenue trajectory ahead of a potential public offering in 2027.

Harvey vs. contract-first legal AI

Harvey raised at a $3B+ valuation on the back of Am Law 100 firm adoption. The question is whether it can penetrate mid-market and in-house legal teams before Microsoft Copilot for Legal erodes the margin opportunity.

Perplexity monetization inflection

Perplexity's enterprise tier has grown to 200+ paying customers but individual subscription conversion remains below 8%. Ad revenue introduced in late 2025 is now being closely watched as the primary path to profitability at scale.

Abridge clinical expansion

Abridge competes with Nuance DAX and Suki in ambient clinical documentation. The next 12 months will test whether its Epic EHR integration depth gives it a sustainable distribution moat or just a first-mover window.

Track startup funding benchmarks on the Funding 2025 dashboard. For VC fundraise data, see VC Fundraises 2026 at Value Add VC.

Frequently Asked Questions

Why is defense AI attracting so much VC capital in 2026?

Three factors converged: the DoD's accelerated procurement timelines for AI-enabled systems, a generation of defense-native founders with clearances and relationships, and LP acceptance of dual-use technology after Anduril and Palantir proved the exit path. Defense AI companies now command premium valuations — often 15–25x ARR — because government contracts provide non-correlated revenue relative to enterprise SaaS cycles.

What is agentic AI and why are those companies raising large rounds?

Agentic AI refers to software systems that autonomously complete multi-step tasks — browsing the web, writing and executing code, managing calendars, filing documents — with minimal human intervention. Companies in this space are raising large rounds because enterprises are paying $50K–$500K annually per deployment, replacing significant headcount. The key metric investors track is tasks-completed-per-dollar versus human labor cost.

How are healthcare AI valuations being set in 2026?

Healthcare AI companies with FDA clearances or payer contracts are commanding 20–35x forward ARR — well above the 6–10x median for enterprise SaaS. The premium reflects regulatory moat and the stickiness of clinical workflow integrations. Companies without regulatory approval trade at much larger discounts because the path to revenue is uncertain and the sales cycle extends 18–36 months.

Are seed and Series A rounds getting crowded out by mega-rounds?

Somewhat. Seed deal count is actually up 8% year-over-year in 2026 as more micro-funds and angel syndicates operate in the $250K–$2M range. But Series A is under pressure: the median Series A has grown to $18M as VCs try to own more of each company earlier, pricing out smaller funds. The real squeeze is at Series B — conversion from A to B has dropped to roughly 38% for non-AI-native software in 2026.

Explore 45+ free VC tools, dashboards, and recommended startup software.